The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary ...

Significant updates on chronic obstructive pulmonary disease (COPD) research included presentations focusing on phosphodiesterase 3/4 inhibitors, biologics targeting type 2 inflammation ...

Severe gum disease has been linked to the progression of chronic obstructive pulmonary disease, or COPD, but an understanding of how the connection plays out in the immune system remains unclear ...

3 Siu DCH, Gafni-Lachter L. Addressing Barriers to Chronic Obstructive Pulmonary Disease (COPD) Care: Three Innovative Evidence-Based Approaches: A Review. Int J Chron Obstruct Pulmon Dis. 2024;19 ...

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an ...

Thorax. 2012;67 (11):957-963. Lindenauer PK, Dharmarajan K, Qin L, et al. Risk Trajectories of Readmission and Death in the First Year After Hospitalization for Chronic Obstructive Pulmonary Disease.

Your Guide to Abnormal Lab Values for Chronic Obstructive Pulmonary Disease (COPD) Different tests Spirometry values Results by stage COPD treatments Takeaway ...

Cite this: Edited by Devyani Gholap. Tiotropium Use in Older Adults With Chronic Obstructive Pulmonary Disease Is Linked to Minimal Dementia Risk - Medscape - June 18, 2025.